Download - Esophagus Diseases
![Page 1: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/1.jpg)
GASTROENTERO-HEPATOLOGY SYSTEM
Centre of Gastroentero-HepatologyDepartment of Internal Medicine
Wahidin Sudirohusodo General Hospital, Makassar2010
![Page 2: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/2.jpg)
Tingkat Kompetensi Dokter
Kemampuan 1 : mengenali & menjelaskan (gambaran klinik, cara mendapat informasi lanjut penyakit, rujukan yang tepat)Kemampuan 2 : diagnosis & merujuk (buat diagnosis, rujukan utk penanganan lanjut, menindaklanjuti setelah kembali dari rujukan)Kemampuan 3 : diagnosis, penatalaksanaan awal, merujuk (A bukan gawat darurat, B gawat darurat)Kemampuan 4 : diagnosis, penatalaksanaan mandiri & tuntas
![Page 3: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/3.jpg)
ESOPHAGUS
![Page 4: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/4.jpg)
ACHALASIA• Lack of relaxation = failure of the LES to relax• Secondary features : aperistalsis of the body of
esophagus• DEFINITION :
primary motor disorder of esophageal smooth muscle function with 3 diagnostic prerequisite
Relatively uncommon, prevalence 10/10.000; incidence 0.5 cases/y/100.000 p.
Acquired disorders affecting any age group (30-60 y.o, uncommon before 25 yo); M=F
Level of competent : 2
![Page 5: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/5.jpg)
Prerequiste diagnostic1. Complete absence of primary &
secondary peristalsis in the smooth muscle, skeletal muscle function normal.
2. LES doesn’t relax completely with swallow
3. Resting LES pressure usually high
![Page 6: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/6.jpg)
Etiology • Remain a mystery • Associated with viral infection
(herpes), autoimmun disorders
![Page 7: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/7.jpg)
Pathophysiology
Myenteric plexus : loss of ganglion cells (inhibitory
function)
relative sparing of cholinergic (stimulatory function)
persistent LES constriction
![Page 8: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/8.jpg)
Clinical manifestation• Dysphagia solid & liquid (most solid food)• Regurgitation 60-90% with bending or
recumbent position,awekening with previous night’s supper in mouth
• Heartburn : fermentation of food in the aperistaltic esophagus
• Weight loss• Chest pain
![Page 9: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/9.jpg)
• Laboratory study : not helpful• Diagnostic study :
BARRIUM SWALLOW : atonic & dilated esophageal body, narrowing of GE junction “bird’s beak”
![Page 10: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/10.jpg)
Thoracic CT scan on a patient with vigorous achalasia demonstrating marked thickening of the distal esophageal wall. The esophageal lumen is not dilated although it is filled with contrast material.
classical radiological features of a dilated esophagus, retained barium and an intralumenalair fl uid level with smooth tapering of the esophagogastric junction.
![Page 11: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/11.jpg)
MANOMETRY : absent distal peristaltis in body (smooth muscle), incomplete LES relaxation (residual > 8mmHg), high resting LES (>45 mmHg)
The corresponding high-resolution manometry depicts the same phenomena with bizarre morphology of the esophageal contractile activity apparent within the distal esophagus and paucity of activity within the proximal esophagus. An increased intrabolus pressure is evident proximal to the nonrelaxing LES
![Page 12: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/12.jpg)
Low (b) and high (c) power views of a myenteric ganglion showing nitric oxide synthase (NOS)- immunoreactive neurons (*). Numerous lymphocytes infi ltrate this region suggesting ongoing chronic infl ammatory activity of the myenteric plexus. Such inflammation may lead to the eventual destruction of the myenteric neurons that characterizes the pathophysiology of achalasia.
![Page 13: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/13.jpg)
• EsophagoGastroDuodenal Endoscopic (role out pseudoachalasia) : observed retained food, esophageal dilatation, feel a’pop’ at GE junction
![Page 14: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/14.jpg)
Differential diagnosis• Secondary achalasia : associated
with various diseases (cancer, chagas’ disease, amyloidosis, mixed connective tissue
• Pseudoachalasia : infiltrating cancer at GE junction (older age, short duration symptom & rapid weight loss)
•
![Page 15: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/15.jpg)
Pseudo-achalasia
Figure (a) Pseudo- or secondary achalasia. The tapering in thedistal esophagus makes this barium esophagram difficult to distinguish from idiopathic achalasia. Note the dilated esophagus with intralumenal air fl uid level. (b) Abdominal CT scan image in a patient with pseudo- or secondary achalasia. This CT image demonstrates a stellate pulmonary mass originating in the left lung invading the gastroesophageal junction.
![Page 16: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/16.jpg)
Esophageal spasm. The corkscrew appearance results from simultaneousnonpropulsive contractions of the esophagus occurring at multiplelevels.
![Page 17: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/17.jpg)
Treatment • Palliative• Directed removing the functional
obstruction at the LES
PHARMACOLOGIC Nitrates, CCB,
botox
ENDOSCOPICPneumatic ballon
dilatationSURGICAL
Heller myotomy
![Page 18: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/18.jpg)
Complication • Esophageal cancer risk 2-7% : mean
interval 17yr, squamous cell type, 5y survival <5%
![Page 19: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/19.jpg)
Reff• Atlas of Gastroenterology (Wiley,
2009)• Primo Gastro (Lippincot, 2008)
![Page 20: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/20.jpg)
CORROSIVE ESOPHAGUS• Injury of esophagus cause by a number of
caustic agent
Epidemiology• Appproximately 26.000 case/year, suicidal
gestsure most common & most injurious compared to accidental ingestion
• 80% case accidentally in children < 5y.o (consumed household cleaners)
Level of competent : 3B
![Page 21: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/21.jpg)
Etiology• Severity of damage depends on
corrosive properties & the consentration
• Alkaline cleaning product = most severe injury
![Page 22: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/22.jpg)
class Caustic agent ProductStrong alkalis Ammonia
Lye (sodium & potasium hydroxide)
Cleaning productDisc battery, drain cleaners, nonphosphate detergent, paint removers, washing products
Strong acid Hydrochloric acid
Nitric acidOxalic acidPhosporic acidSulfuric acid
Muriatic acid, soldering fluxes, swimming poool cleaners, toilet bowel cleanersGun barrel cleanersAntirust compoundsToilet bowel cleanersBattery acid, toilet bowel cleaners
Miscellanous Sodium hypochlorite Liquid bleach
![Page 23: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/23.jpg)
Pathopysiology• Alkali Esophagitis : liquefactive necrosis
(complete destruction of entire cell & membranes)
Phase of InjuryAcute (day 1-4) liquefactive necrosis ; sloughing or
ulcer not apparent <24hr, vascular thrombosis, inflammation
Subacute (day 5-14) Sloughing casts; esophageal wall is thinnest, granulation, fibroblast/collagen deposition
Cicatrization (day 15-3mon) Fibroblast proliferate, further collagen deposition, stricture formation, epithelization
![Page 24: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/24.jpg)
• Acid esophagitis : coagulation necrosis with clumping & opaficationof celluler cytoplasm, retained cell boundaries
Clinical Manifestation• Early sign &symptoms not realible
indicator of the severity• A history of chemical ingestion and
physical examination revealing oropharyngeal burns (including white membranes and edema of the soft palate and uvula) usually confirm the diagnosis.
• intense pain in the mouth and anterior chest
• marked salivation • inability to swallow and tachypnea. • Bloody vomitus containing pieces of
esophageal tissue signals severe damage• Signs of esophageal perforation and
mediastinitis, especially crepitation, indicate destruction of the entire esophagus.
• Inability to speak implies laryngeal damage.
![Page 25: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/25.jpg)
Laboratory study : not helpful
Diagnostic study :• Endoscopy (in the first 24 hours after
ingestion) delineates the extent and location of the esophageal injury and assesses the depth of the burn; (a week after ingestion) to assess stricture development.
• Barium swallow (1 week afteringestion and every 3 weeks thereafter) may identify segmental spasm or fistula (no mucosal injury)
![Page 26: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/26.jpg)
Classification of injury by endoscopy
Endoscopic findings
Hospital stay
Risk of stricture
Treatment
No injury None None DischargeGastric only Observe 24-
48 hrsNone Liquid diet
Linear esophageal injury
Observe 24-48 hrs
Low Liquid diet
Circumferential injury
Observe at least 48 hrs
High NPO, NGT
![Page 27: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/27.jpg)
Treatments• ABC, need for intubation?,
obvious sign of mediatinitis/peritonitis requiring injury
• Determine quantitiy & type ofcaustic agent and time ingestion; is the container available?
• Emesis should not be induced (re-exposed esophagus & larynx)
• NG lavage is controversial, potential risk include vomiting, perforation. If NG place, aspirate before cold lavage
![Page 28: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/28.jpg)
• If known acid & within minute injury :large volume water/milk may dilute & neutralize acid; otherwise NPO
• Steroid : reduce potential for stricture to high risk lesions, however no consensus on their use.- should only use in circumferential injury :
prednisone 1.5mg/kg/d & tapered over 2 months- probably use in patients with airway compromise & bronchospasm
![Page 29: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/29.jpg)
• Antibiotics : role has never been established (ampicillin)
• In acute setting, get CXR or CT to role out perforation before endoscopy
• Prophylactic dilatation once acute injury has resolved (3rd week)
• Supportive treatment includes I.V. therapy to replace fluids or total parenteral nutrition while the patient can’t swallow, gradually progressing to clear liquids and a soft diet.
![Page 30: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/30.jpg)
Complication• Strictures
• Esophageal cancer : 1000x fold risk, begin endoscopy survailence 15 years after ingestion (every1-3 years)
![Page 31: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/31.jpg)
HIATUS HERNIALevel of competent : 2
![Page 32: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/32.jpg)
GASTRITISLevel of competent : 4
![Page 33: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/33.jpg)
Variceal GI bleeding
Level of competent : 2
![Page 34: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/34.jpg)
VARICES ESOPHAGUS• Prevalance : 50% of all cirrhotic (80% in
Child C, 20% in Child A)• Incidence : 10% per year in cirrhotic• Variceal bleeding :
- incidence :24% per 2 years w/ moderate to large v.; 50% acute bleeding
- mortality : >20% w/1st bleed; 70% 5 y. mortality; 40-50% will rebleed
![Page 35: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/35.jpg)
Architectural disturbances
Increased hepatic vascular resistence
Garcia-Pagan JC, Grozmann RJ, Bosch J. In Clinical Gastroenterology and Hepatology. 2005; p.709.
![Page 36: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/36.jpg)
Pathophysiology Portal hypertension : an increase in the portal
venous pressure gradient (PVPG) and is a function of portal venous blood flow and hepatic and portocollateral resistence
Hepatic venous wedge pressure gradient (HVWPG) : represent the pressure difference between the wedge hepatic vein (pv pressure) & direct mesurement of abdominal IVC (free hv pressure)≈ 6 mmHg normally, > 10mmHg variceal development, >12mmHg high risk bleeding
![Page 37: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/37.jpg)
MAJOR SITE COLLATERAL
![Page 38: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/38.jpg)
Opening of pre-existingVascular communication
Increases in portal pressureand portal collateral bloodflow by meals, alcohol,physical exercise, increasedintraabdominal pressure
Garcia-Pagan JC, Grozmann RJ, Bosch J. In Clinical Gastroenterology and Hepatology. 2005; p.709.
Risk factors for rebleeding
- Age > 60 y.o.- Large varices- Severe initial bleed
(Hb <8 g/dl on admission)
- Renal failureOnly 50% of patients
with variceal hemorrhage stop bleeding spontaneously & high risk to recurrent bleeding within 6 weeks
![Page 39: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/39.jpg)
COLLATERAL CIRCULATION(VARICES)
![Page 40: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/40.jpg)
• Clinical manifestation : upper GI bleeding• Laboratory study : Hb/Ht, PT/APTT
(bleeding)• Diagnostic study : screening UGIE
- no varices : repeat EGD 2-3y, no prophylaxis necessary- s. varices : repeat EGD 1-2y, consider β-bloker if Child C- m to L.varices : 1st prevention EBL, β-bloker, etc
![Page 41: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/41.jpg)
Fig. 4. Esophageal varices. a. Large variceal columns b. Varix with cherry-red spot
c. Varix with red wale sign
Fig. Portal Hypertensive Gastropathy (PHG) a. Mild portal hypertensive
gastropathyb. Severe PHG with active
oozing
a b c
a bWu et al. Gastroenterological endoscopy 2002: 541-543
![Page 42: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/42.jpg)
Treatment PHARMACOTHERAPY
• VASOCONSTRICTORS decrease in splanchnic blood flow & leads to decrease in portal venous blood flow and portal pressure (e.g vasopressin, somatostatin, nonselective β-bloker)
• VASODILATORS alter resistence by inducing changes in the intrahepatic perivenular & perisinusoidal myofibroblast as the smooth muscle component of portocollateral vessels (e.g. nitroglycerine, long acting nitrate, prazosine)
![Page 43: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/43.jpg)
Acute Bleeding• Transfuse Hb to 8gm/dl (aggressive transfusion may
precipitate further portal hypertension & bleeding)consider : platelets, FFP, lactulosa, endotracheal intubation
• Pharmacologic (start immediately, do not wait EGD to perform)
- octreotide : 50mcg Iv bolus then 50mcg/hr infusion, continue for 4-7 day
- PPI : IV drip until po can be taken- Antibiotics : all variceal bleeding should get against bacterial gut (3rd generation) during hospitalization for 4-7 days
Once stable, BB (propanolol/nadolol ± nitrate) after EGD
![Page 44: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/44.jpg)
Table 2. Pharmacologic treatment of acute variceal bleeding
Drug route administration DoseVasopressinNitroglycerine
i.Vi.v Continous infusion 0.1-0.4 U/min
40-400 g/minGlypressin i.V Initial bolus
Subsequent bolus2 mg/4 h1-2 mg/4 h
Somatostatin i.V Initial bolusContinous infusion
250-500 g250-500 g/h
Octreotide i.V Initial bolusContinous infusion
25-50 g25-50 g/h
Terlipressin i.v Initial bolusSubsequent bolus
2 mg/4-6h in 2d1mg/4-6h
Treatment should be continued for 5 days
![Page 45: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/45.jpg)
Prophylaxis of variceal bleeding in cirrhosis. Preprimary prophylaxis is aimed at preventing esophagogastric varices (EV) from developing. The goal of primary prophylaxis is to prevent a first variceal bleeding episode once medium or large varices have formed. Secondary prophylaxis is used to prevent recurrent variceal bleeding. Photo by: Lianne Friesen and Nicholas Woolridge
![Page 46: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/46.jpg)
Table 1. Pharmacologic treatment for prevention of variceal bleeding
Drug Initial Dose Therapeutic dose
Propanolol 40 mg bid 40-400 mg Nadolol 40 mg qd 40-160 mg
Timolol 10 mg qd 5 mg qd-40mg
Isosorbide 5-mononitrate
20 mg bid 20 mg tid-20 mg qd
Goal : 20% reduction in HVWPG or 25% heart rate; decreased bleeding risk 50-90% (only 35% patients achieve this goal)
![Page 47: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/47.jpg)
Complication of Variceal bleeding• Syock hypovolemik death• Induce :
– Hepatic encephalopathy– Hepatorenal syndrome– Worsening clotting profile
SA Jenkins, Somatostatin and ocreotide in gastroenterology, Medimedia, 1996
![Page 48: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/48.jpg)
Prognosis• Primary prevention
indicated : moderate-large v. >5mm in D- nonselective BB ±nitrate (50% bleeding)- band ligation (more greater than BB in
bleeding)• Secondary prevention
indicated : patients who has previously bleed; >80% will bleed againin 2 years- band ligation ± nonselective BB with nitrates- if continue to rebleed > TIPS/transplant
![Page 49: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/49.jpg)
PLEASE READ KONSENSUS NASIONAL PERKUMPULAN
GASTROENTEROLOGI INDONESIA (PGI) 2007Panduan penatalaksanaan perdarahn varises pada sirosis hati
![Page 50: Esophagus Diseases](https://reader035.vdocuments.net/reader035/viewer/2022081416/5695d0741a28ab9b0292868f/html5/thumbnails/50.jpg)
• The key factor in the natural history of esophageal varices is increased portal pressure, which in cirrhosis is due to the combination of increased hepatic vascular resistance and increased portal collateral blood flow. The maintenance and aggravation of this situation leads to the progressive dilation of the varices and thinning of the variceal wall, until the tension exerted by the variceal wall exceeds the elastic limit of the vessel, leading to variceal hemorrhage